Clinical Trial: A Multicenter, Randomized, Double-Blind, Parallel-Controlled Study to Evaluate the Efficacy and Safety of Sitokiren Malate Tablets Combined with Amlodipine Besylate Tablets in the Treatment of Patients with Primary Mild to Moderate Hypertension Complicated with Risk of Early Renal Injury (China)

China, Sept. 29 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'A Multicenter, Randomized, Double-Blind, Parallel-Controlled Study to Evaluate the Efficacy and Safety of Sitokiren Malate Tablets Combined with Amlodipine Besylate Tablets in the Treatment of Patients with Primary Mild to Moderate Hypertension Complicated with Risk of Early Renal Injury'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600133505

Registration Time: 2026/09/28

Type: Interventional study

Primary Sponsor: Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=345558

Published by HT D...